Campbell P. Howard

Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen

Paul M. Ridker, Campbell P. Howard, Verena Walter et al. · Circulation · 2012 · 529 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Insulin Growth Factor-Based Dosing of Growth Hormone Therapy in Children: A Randomized, Controlled Study

Pinchas Cohen, Alan D. Rogol, Campbell P. Howard et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 154 citations

Pharmacy, Child Health, Endocrinology +17

Effect of anti‐ <scp>IL</scp> ‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled trial

A Rissanen, Campbell P. Howard, Jaco Botha et al. · Diabetes Obesity and Metabolism · 2012 · 141 citations

Medicine, Endocrinology, Pharmacology +17

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

Julio Rosenstock, Daniel L. Lorber, Luigi Gnudi et al. · The Lancet · 2010 · 126 citations

Medicine, Clinical Sciences, Endocrinology +13

Impact of interleukin-1β antibody (canakinumab) on glycaemic indicators in patients with type 2 diabetes mellitus: Results of secondary endpoints from a randomized, placebo-controlled trial

J. Hensen, Campbell P. Howard, Verena Walter et al. · Diabetes & Metabolism · 2013 · 107 citations

Medicine, Endocrinology, Immunology +17